Skip to main content
SpringerLink
Log in

Blockade of Integrin VLA-4 Prevents Inflammation and Matrix Metalloproteinase Expression in a Murine Model of Accelerated Collagen-Induced Arthritis

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

DBA/1LacJ mice were immunized with type II collagen and boosted with bacterial lipopolysaccharide (LPS) 17 days later to induce accelerated arthritis. Clinical signs of inflammation were observed as early as Day 20. Matrix metalloproteinases MMP-2, -3, -9, and -13, but not MMP-12, mRNA levels were increased on Day 24. Administration of anti-VLA-4 antibody (mAb; 8 mg/kg/day for 3 days) at the time of LPS treatment strikingly inhibited arthritis-induced paw inflammation and histological scores, but not the increase in MMP expression. A higher dose of mAb (20 mg/kg/day for 4 days) inhibited pathology and normalized the levels of MMP mRNAs. In conclusion, the pathophysiology of this accelerated model of arthritis is VLA-4-dependent, and VLA-4-mediated events have a role in inflammation-induced MMP expression. Inhibition of arthritis-induced increases in MMP expression is not necessary to reduce pathology. This model is well suited for identifying agents that block integrin VLA-4 in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hynes, R. O. 1992. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11–25.

    Google Scholar 

  2. Hemler, M. E. 1990. VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Annu. Rev. Immunol. 8:365–400.

    Google Scholar 

  3. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425–433.

    Google Scholar 

  4. Faveeuw, C., M. D. Di Mauro, A. A. Price, and A. Ager. 2000. Roles of alpha(4) integrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial migration of T lymphocytes and T lymphoblasts across high endothelial venules. Int. Immunol. 12:241–251

    Google Scholar 

  5. Meerschaert, J. and M. B. Furie. 1994. Monocytes use either CD11/CD1 or VLA-4 to migrate across human endothelium in vitro. J. Immunol. 152:1915–1926.

    Google Scholar 

  6. Issekutz, T. B. 1991. Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody: A likely role for VLA-4 in vivo. J. Immunol. 147:4178–4184.

    Google Scholar 

  7. Issekutz, A. C. and T. B. Issekutz. 1995. Monocyte migration to arthritis in the rat utilizes both CD11/CDS18 and very late activation antigen 4 integrin mechanisms. J. Exp. Med. 181:1197–1203.

    Google Scholar 

  8. Lobb, R. R. and M. E. Hemler. 1994. The pathophysiologic role of α 4 integrins in vivo. J. Clin. Invest. 94: 1722–1728.

    Google Scholar 

  9. Tamraz, S., T. Arrhenius, A. Chiem, M. J. Forrest, F. C. A. Gaeta, Y. Bhe, J. Lei, A. Maewal, M. L. Phillips, L. W. Vollger, and M. J. Elices. 1995. Treatment of delayed-type hypersensitivity with inhibitors of the VLA-4 integrin. Springer Semin. Immunopathol. 16:437–441.

    Google Scholar 

  10. Issekutz, A. C., L. Ayer, M. Miyasaka, and T. B. Issekutz. 1996. Treatment of established adjuvant arthritis in rats with monoclonal antibody to CD18 and very late activation antigen-4 integrins suppresses neutrophil and T-lymphocyte migration to the joints and improves clinical disease. Immunology 88:569–576.

    Google Scholar 

  11. Barbadillo, C., J. L. Andreu, J. Mulero, and F. Sanchez-Madrid. 1993. Anti-VLA-4 mAb prevents adjuvant arthritis in Lewis rats. Arthritis Rheum. 36:S95.

    Google Scholar 

  12. Steinman, L. and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4/β1 integrin. Nature 356:63–66.

    Google Scholar 

  13. Caccese, R. G., J. L. Zimmerman, and R. P. Carlson. 1992. Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators Inflamm. 1:273–279.

    Google Scholar 

  14. Stuart, J. M., A. S. Townes, and A. H. Kang. 1982. The nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69:673–683.

    Google Scholar 

  15. Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunization against heterologous type II collagen-induced arthritis in mice. Nature 283:666–668.

    Google Scholar 

  16. Killar, L. M. and C. J. Dunn. 1989. Interleukin-1 potentiates the development of collagen arthritis in mice. Clin. Sci. 76: 535–538.

    Google Scholar 

  17. Hom, J. T., A. M. Bendele, and D. G. Carlson. 1988. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J. Immunol. 141:834–841.

    Google Scholar 

  18. Romanic, A. M. and J. A. Madri. 1994. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125:1165–1178.

    Google Scholar 

  19. Kambara, C., T. Nakamura, T. Furuya, K. Migita, H. Ida, A. Kawakami, S. Shirabe, S. Nakane, I. Kinoshita, and K. Eguchi. 1999. Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 99:242–247.

    Google Scholar 

  20. Madri, J. A., D. Graesser, and T. Hass. 1996. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem. Cell Biol. 74: 749–757.

    Google Scholar 

  21. Graesser, D. S. Mahooti, T. Hass, S. Davis, R. B. Clark, and J. A. Madri. 1998. The interrelationship of α-4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab. Invest. 78:1445–1458.

    Google Scholar 

  22. Graesser, D., S. Mahooti, and J. A. Madri. 2000. Distinct roles of matrix metalloproteinase-2 and α-4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 109:121–131.

    Google Scholar 

  23. Xia M., S. P. Sreedharan, P. Dazin, C. H. Damsky, and E. J. Goetzl. 1996. Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane. J. Cell Biochem. 61:452–458.

    Google Scholar 

  24. Pender, S. L., M. T. Salmela, G. Monteleone, D. Schnapp, C. Mckenzie, J. Spencer, S. Fong, U. Saarialho-Kere, and T. T. Macdonald. 2000. Ligation of α4β1 integrin on human intestinal mucusal mesenchymal cells selectively upregulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. Am. J. Pathol. 157:1955–1962.

    Google Scholar 

  25. Huhtala, P., M. Humphries, J. Mccarthy, P. Tremble, Z. Werb, and C. Damsky. 1995. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129: 867–879.

    Google Scholar 

  26. Birkedal-Hansen H., W. G. Moore, M. K. Bodden, L. J. Windsor, B. Birkedal-Hansen, A. Decarlo, J. A. Engler. 1993. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med 4:197–250.

    Google Scholar 

  27. Kerkela, E., T. Bohling, R. Herva, J. A. Uria, U. Saarialho-Kere. 2001. Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation. Bone 29:487–493.

    Google Scholar 

  28. Mccachren, S. S. 1991. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum. 34:1085–1093.

    Google Scholar 

  29. Firestein, G. S., M. M. Paine, and B. H. Littman. 1991. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitiative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 34:1094–1105.

    Google Scholar 

  30. Hasty, K. A., R. A. Reife, A. H. Kang, and J. M. Stuart. 1990. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum. 33:388–397.

    Google Scholar 

  31. Case, J. P., H. Sano, R. Lafyatis, E. F. Remmers, G. K. Kumkumian, and R. L. Wilder. 1989. Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. J. Clin. Invest. 84:1731–1740.

    Google Scholar 

  32. Cambray, G. J., G. Murphy, G. D. P. Page-Thomas, and J. J. Reynolds. 1981. The production in culture of metalloproteinases and inhibitor by joint tissues from normal rabbits and from rabbits with a model arthritis. I Synovium. Rheumatol. Int. 1:11–16.

    Google Scholar 

  33. Ahrens, D., A. E. Koch, R. M. Pope, H. Steinpicarella, and M. J. Niedbala. 1996. Expression of matrix metalloproteinase 9 (96-kd gelatinase-B) in human rheumatoid arthritis. Arthritis Rheum. 39:1576–1587.

    Google Scholar 

  34. Fosang, A. J., K. Last, V. Knauper, G. Murphy, and P. J. Neame. 1996. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380:17–20.

    Google Scholar 

  35. Fosang A. J., P. J. Neame, T. E. Hardingham, G. Murphy, and J. A. Hamilton. 1991. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J. Biol. Chem. 266:15579–15582.

    Google Scholar 

  36. Lark, M. W., E. K. Bayne, J. Flanagan, C. F. Harper, L. A. Hoerrner, N. I. Hutchinson, I. I. Singer, S. A. Donatelli, J. R. Weidner, H. R. Williams, R. A. Mumford, and L. S. Lohmander. 1997. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic and rheumatoid joints. J. Clin. Invest. 100:93–106.

    Google Scholar 

  37. Singer, I. I., D. W. Kawka, E. K. Bayne, S. A. Donatelli, J. R. Weidner, H. R. Williams, J. M. Ayala, R. A. Mumford, M. W. Lark, T. T. Glant, G. H. Nabozny, and C. S. David. 1995. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95:2178–2186.

    Google Scholar 

  38. Singer, I. I., S. Scott, D. W. Kawka, E. K. Bayne, J. R. Weidner, H. R. Williams, R. A. Mumford, M. W. Lark, J. Mcdonnell, A. Christen, V. L. Moore, J. S. Mudgett, and D. M. Visco. 1997. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen IL-1 induced arthritis. Osteoarthritis Cartilage 5:407–418.

    Google Scholar 

  39. Miyake, K., I. L. Weissman, J. S. Greenberger, and P. W Kincade. 1991. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. 173:599–607.

    Google Scholar 

  40. Jeng, A. Y., M. Chou, W. K. Sawyer, S. L. Caplan, J. V. Linden-Reed, M. Jeune, and M. F. Prescott. 1999. Enhanced expression of matrix metalloproteinase-3,-12, and-13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis. Ann. N.Y. Acad. Sci. 878:555–558.

    Google Scholar 

  41. Chrisholm, P. L., C. A. Williams, and R. R. Lobb. 1993. Monoclonal antibodies to the integrin alpha-4 subunit inhibit the murine contact hypersensitivity response. Eur. J. Immunol. 23:682–688.

    Google Scholar 

  42. Seiffge, D. 1996. Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats. J. Rheumatol. 23:2086–2091.

    Google Scholar 

  43. Zeidler, A., R. Bräuer, K. Thoss, J. Bahnsen, V. Heinrichs, D. Jablonski-Westrich, M. Wroblewski, S. Rebstock, and A. Hamann. 1995. Therapeutic effects of antibodies against adhesion molecules in murine collagen type II-induced arthritis. Autoimmunity 21:245–252.

    Google Scholar 

  44. Beckett, R. P. 1996. Recent advances in the field of matrix metalloproteinase inhibitors. Exp. Opin. Ther. Patents 6:1305–1315.

    Google Scholar 

  45. Beckett, R. P., and M. Whittaker. 1998. Matrix metalloproteinase inhibitors. Exp. Opin. Ther. Patents 8:259–282.

    Google Scholar 

  46. Cawston, T. E. 1996. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 70:163–182.

    Google Scholar 

  47. Fujisawa, T., K. Igeta, S. Odake, Y. Morita, J. Yasuda, T. Morikawa. 2002. Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model. Bioorg. Med. Chem. Lett. 10:2569–2581.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Novartis Institute for Biomedical Research, Summit, New Jersey, 07901

    Anil Raychaudhuri, Mary Chou, Marla Weetall & Arco Y. Jeng

Authors
  1. Anil Raychaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Chou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marla Weetall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arco Y. Jeng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marla Weetall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raychaudhuri, A., Chou, M., Weetall, M. et al. Blockade of Integrin VLA-4 Prevents Inflammation and Matrix Metalloproteinase Expression in a Murine Model of Accelerated Collagen-Induced Arthritis. Inflammation 27, 107–113 (2003). https://doi.org/10.1023/A:1023282701505

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023282701505

Search

Navigation